Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
J Card Fail. 2010 Mar;16(3):218-24. doi: 10.1016/j.cardfail.2009.11.002. Epub 2009 Dec 11.
Right ventricular (RV) dysfunction is associated with adverse outcomes in heart failure (HF). Mechanical unloading should be more effective than pharmacologic therapy to reduce RV afterload and improve RV function. We compared RV size and function after aggressive medical unloading therapy to that achieved in the same patients after 3 months of left ventricular assist device (LVAD) support.
We studied 20 patients who underwent isolated LVAD placement (9 pulsatile and 11 axial flow). Echocardiograms were performed after inpatient optimization with diuretic and inotropic therapy and compared with studies done after 3 months of LVAD support. After medical optimization right atrial pressure was 11 +/- 5 mm Hg, mean pulmonary artery pressure 36 +/- 11 mm Hg, pulmonary capillary wedge pressure 23 +/- 9 mm Hg, and cardiac index 2.0 +/- 0.6 L.min.m(2). Preoperatively, RV dysfunction was moderate (2.6 +/- 0.9 on a 0 to 4 scale), RV diameter at the base was 3.1 +/- 0.6 cm, and mid-RV was 3.5 +/- 0.6 cm. After median LVAD support of 123 days (92 to 170), RV size and global RV dysfunction (2.6 +/- 0.9) failed to improve, despite reduced RV afterload.
RV dysfunction seen on intensive medical therapy persisted after 3 months of LVAD unloading therapy. Selection of candidates for isolated LV support should anticipate persistence of RV dysfunction observed on inotropic therapy.
右心室(RV)功能障碍与心力衰竭(HF)的不良结局相关。机械卸载应该比药物治疗更有效,以减少 RV 后负荷并改善 RV 功能。我们比较了积极的药物卸载治疗后 RV 的大小和功能与相同患者在左心室辅助装置(LVAD)支持 3 个月后所达到的效果。
我们研究了 20 例接受单纯 LVAD 植入的患者(9 例搏动性和 11 例轴流)。在进行利尿和正性肌力药物治疗的住院优化后进行超声心动图检查,并与 LVAD 支持 3 个月后的研究进行比较。在药物优化后,右心房压为 11 ± 5 mmHg,平均肺动脉压为 36 ± 11 mmHg,肺毛细血管楔压为 23 ± 9 mmHg,心指数为 2.0 ± 0.6 L.min.m(2)。术前 RV 功能障碍为中度(0 至 4 级的 2.6 ± 0.9),RV 基底直径为 3.1 ± 0.6 cm,中 RV 直径为 3.5 ± 0.6 cm。在中位数为 123 天(92 至 170)的 LVAD 支持后,尽管 RV 后负荷降低,但 RV 大小和整体 RV 功能障碍(2.6 ± 0.9)仍未改善。
尽管在 LVAD 卸载治疗后进行了强化药物治疗,但仍存在 RV 功能障碍。对于孤立性 LV 支持的候选者的选择应预测到在正性肌力治疗中观察到的 RV 功能障碍的持续存在。